Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure

BACKGROUND: Current therapies for anemia of chronic kidney disease (CKD) include administration of supplemental iron (intravenous and/or oral), blood transfusions and replacement of erythropoietin through the administration of recombinant human erythropoietin (rhEPO) and rhEPO analogs, each with lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Caltabiano, Stephen, Cizman, Borut, Burns, Olivia, Mahar, Kelly M, Johnson, Brendan M, Ramanjineyulu, Bandi, Serbest, Gulyeter, Cobitz, Alexander R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Anemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768310/
https://www.ncbi.nlm.nih.gov/pubmed/31583094
http://dx.doi.org/10.1093/ckj/sfz013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768310/
https://www.ncbi.nlm.nih.gov/pubmed/31583094
http://dx.doi.org/10.1093/ckj/sfz013

Ejemplares similares